Since mTOR signaling is broadly implicated in cancer, metabolic disease, and neurological diseases, dual inhibition of the mTOR signaling pathway through gene therapy may be the most promising clinical strategy beyond neuropathic pain. This evidence concerns the gene MTOR and nervous system disorder.